Detalhe da pesquisa
1.
Effect of Eplontersen on Cardiac Structure and Function in Patients With Hereditary Transthyretin Amyloidosis.
J Card Fail;
2023 Dec 07.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38065307
2.
Eplontersen for Hereditary Transthyretin Amyloidosis With Polyneuropathy.
JAMA;
330(15): 1448-1458, 2023 10 17.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37768671
3.
Liver-directed drugs for transthyretin-mediated amyloidosis.
J Peripher Nerv Syst;
27(4): 228-237, 2022 12.
Artigo
em Inglês
| MEDLINE
| ID: mdl-36345805
4.
Tafamidis Treatment for Patients with Transthyretin Amyloid Cardiomyopathy.
N Engl J Med;
379(11): 1007-1016, 2018 Sep 13.
Artigo
em Inglês
| MEDLINE
| ID: mdl-30145929
5.
Inotersen Treatment for Patients with Hereditary Transthyretin Amyloidosis.
N Engl J Med;
379(1): 22-31, 2018 Jul 05.
Artigo
em Inglês
| MEDLINE
| ID: mdl-29972757
6.
Feasibility of assessing progression of transthyretin amyloid polyneuropathy using nerve conduction studies: Findings from the Transthyretin Amyloidosis Outcomes Survey (THAOS).
J Peripher Nerv Syst;
26(2): 160-166, 2021 06.
Artigo
em Inglês
| MEDLINE
| ID: mdl-33844361
7.
Neuropathy symptom and change: Inotersen treatment of hereditary transthyretin amyloidosis.
Muscle Nerve;
62(4): 509-515, 2020 10.
Artigo
em Inglês
| MEDLINE
| ID: mdl-32654156
8.
Randomized Trial of Thymectomy in Myasthenia Gravis.
N Engl J Med;
375(6): 511-22, 2016 08 11.
Artigo
em Inglês
| MEDLINE
| ID: mdl-27509100
9.
Inflammatory profiling of patients with familial amyloid polyneuropathy.
BMC Neurol;
19(1): 146, 2019 Jun 28.
Artigo
em Inglês
| MEDLINE
| ID: mdl-31253122
10.
Estimating the global prevalence of transthyretin familial amyloid polyneuropathy.
Muscle Nerve;
57(5): 829-837, 2018 05.
Artigo
em Inglês
| MEDLINE
| ID: mdl-29211930
11.
Assessing mNIS+7Ionis and international neurologists' proficiency in a familial amyloidotic polyneuropathy trial.
Muscle Nerve;
56(5): 901-911, 2017 Nov.
Artigo
em Inglês
| MEDLINE
| ID: mdl-28063170
12.
Real-life experience with inotersen at CEPARM, Hospital Universitário Clementino Fraga Filho, Universidade Federal do Rio de Janeiro.
Arq Neuropsiquiatr;
82(4): 1-7, 2024 Apr.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38579737
13.
Clinical and Genotype Characteristics and Symptom Migration in Patients With Mixed Phenotype Transthyretin Amyloidosis from the Transthyretin Amyloidosis Outcomes Survey.
Cardiol Ther;
13(1): 117-135, 2024 Mar.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38117424
14.
Phenotypic characteristics of F64L, I68L, I107V, and S77Y ATTRv genotypes from the Transthyretin Amyloidosis Outcomes Survey (THAOS).
PLoS One;
19(1): e0292435, 2024.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38241252
15.
Hereditary transthyretin amyloid neuropathies: advances in pathophysiology, biomarkers, and treatment.
Lancet Neurol;
22(11): 1061-1074, 2023 11.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37863593
16.
Optimal practices for the management of hereditary transthyretin amyloidosis: real-world experience from Japan, Brazil, and Portugal.
Orphanet J Rare Dis;
18(1): 323, 2023 10 12.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37828588
17.
A multicentric study of the disease risks and first manifestations in hereditary transthyretin amyloidosis (ATTRv): insights for an earlier diagnosis.
Amyloid;
30(3): 313-320, 2023 Sep.
Artigo
em Inglês
| MEDLINE
| ID: mdl-36994840
18.
Brazilian consensus for diagnosis, management and treatment of hereditary transthyretin amyloidosis with peripheral neuropathy: second edition.
Arq Neuropsiquiatr;
81(3): 308-321, 2023 03.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37059440
19.
A 15-year consolidated overview of data in over 6000 patients from the Transthyretin Amyloidosis Outcomes Survey (THAOS).
Orphanet J Rare Dis;
18(1): 350, 2023 Nov 10.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37946256
20.
Characteristics of Patients with Hereditary Transthyretin Amyloidosis-Polyneuropathy (ATTRv-PN) in NEURO-TTRansform, an Open-label Phase 3 Study of Eplontersen.
Neurol Ther;
12(1): 267-287, 2023 Feb.
Artigo
em Inglês
| MEDLINE
| ID: mdl-36525140